ABSI Stock Summary and Trading Ideas (Absci | NASDAQ:ABSI)

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.

Absci trades on the NASDAQ stock market under the symbol ABSI.

As of July 28, 2026, ABSI stock price declined to $7.13 with 2,692,269 million shares trading.

ABSI has a beta of 1.78, meaning it tends to be more sensitive to market movements. ABSI has a correlation of 0.06 to the broad based SPY ETF.

ABSI has a market cap of $1.21 billion. This is considered a Small Cap stock.

Last quarter Absci reported $215,000 in Revenue and -$.19 earnings per share. This fell short of revenue expectation by $-1 million and exceeded earnings estimates by $.01.

In the last 3 years, ABSI traded as high as $12.06 and as low as $1.11.

The top ETF exchange traded funds that ABSI belongs to (by Net Assets): ARKG, VTI, XBI, IWM, VXF.

ABSI has outperformed the market in the last year with a return of +140.1%, while the SPY ETF gained +17.5%. In the last 3 month period, ABSI beat the market returning +46.7%, while SPY returned +4.4%. However, in the most recent 2 weeks ABSI has underperformed the stock market by returning -30.3%, while SPY returned -1.5%.

ABSI support price is $7.13 and resistance is $7.99 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ABSI shares will trade within this expected range on the day.